Population pharmacokinetics of long-term oral amiodarone therapy

Population pharmacokinetic modeling of long-term oral amiodarone confirms its extraordinarily long terminal half-life of 55 days and provides a practical dosing regimen to rapidly achieve and maintain therapeutic concentrations.